Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
INVESTIGATION OF IDH1/2 MUTATIONS IN PATIENTS WITH LEUKEMIA COMPARED WITH THE IDH1/2 MUTATIONS IN GLIOMA PATIENTS
البحث عن الطفرات الوراثية في جينات IDH1/2 في مرضى سرطان الدم ومقارنة النتائج مع الطفرات الوراثية لنفس الجينات في مرضى ورم الدماغ
Subject
:
Faculty of Applied Medical Sciences
Document Language
:
Arabic
Abstract
:
Introduction. Different forms of human cancer show mutations for isocitrate dehydrogenases 1 and 2 (IDH1/2) genes. The alterations mainly occur in cytogenetically normal acute myeloid leukemia (AML), resulting in over-generation of an oncometabolite, D-2-hydroxyglutarate (D-2-HG). Besides, the most prevalent IDH1/2 mutation in glioma is glioblastoma (GBM). Aim of the Study. The study aims at identifying the prevalence of IDH1/2 mutation in AML. Furthermore, the report describes the association of the mutations with their clinical implication in disease prognosis. Moreover,the differences of IDH1/2 mutations in leukemia patients compared to those with glioma will be investigates. Subjects and Methods: The research entails 27 DNA samples derived from bone marrows of AML patients. In the case of glioma, IDH1/2 mutation-related details were acquired from the Center of Excellence in Genomic Research (CEGMR) and were based on a previous study performed at the center. The alteration hotspots in codon IDH-R132 and IDH-R172 on Exon 4 are examined via sequencing. Clinical data of patients were taken and utilized in the analysis. The findings on leukemia-related mutations were compared with the mutation results of similar genes on glioma patients from the provided information. Results. Mutation in IDH1 gene was detected in 6 out of 27 (22%) AML patients, 4 of them (14.8%) occur at codon 132. The other two mutations include single nucleotide polymorphism (rs11554137) which affect codon G105 in one patient and another synonymous mutations (rs767243751) affecting codon R135 was detected in a separate sample. However, there is no mutation detected on IDH2 gene. The connection between AML and glioma in terms of IDH1/2 mutation was studied. Lastly, cytogenetic effects and molecular screening were conducted. The predominance of IDH1 in AML was approximately 22%, while in glioma it was 78%. Conclusion and Recommendations. While the present study comprised of a small sample size, the findings indicate that IDH1 is a potential target in AML diagnosis.
Supervisor
:
Dr. Heba Alkhatabi
Thesis Type
:
Master Thesis
Publishing Year
:
1441 AH
2019 AD
Added Date
:
Wednesday, November 13, 2019
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
حنين عبد الفتاح صديق
Saddeq, Haneen Abdulfattah
Researcher
Master
Files
File Name
Type
Description
45162.pdf
pdf
Back To Researches Page